News and Announcements
Global Drug Giant Merck is Investing in Australian Biopharmaceutical Bionomics
- Published October 09, 2015 2:36PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
8th October 2015, By Chris Pash, Business Insider
Global drug giant Merck & Co has made a strategic investment in an Australia biopharmaceutical company Bionomics, which works on the discovery and development of treatment for cancer and diseases of the central nervous system.
Merck, one of the largest pharmaceutical companies in the world, is buying 21,659,230 million shares at $0.5938, a 29% premium to Bionomics’ closing price on Wednesday, a total investment of about $12.8 million.
The news sent Bionomics shares more than 18% higher to $0.545.
To read the full story, please click here.